MTOR and colorectal carcinoma: In summary, therapeutic blockade of both PI3K–Akt–mTOR and DNA damage pathway signaling shifted the 5′-C transcript levels of signature genes in radiotherapy-resistant CRC lines towards that in more radiosensitive lines.